Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcoma The European Organisation for Research and Treatment of Cancer – Soft Tissue and Bone Sarcoma Group (STBSG) and French Sarcoma Group (FSG) study

BACKGROUND: We investigated prognostic factors (PFs) for 90-day mortality in a large cohort of advanced/metastatic soft tissue sarcoma (STS) patients treated with first-line chemotherapy. METHODS: The PFs were identified by both logistic regression analysis and probability tree analysis in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Penel, N, Glabbeke, M V, Mathoulin-Pelissier, S, Judson, I, Sleijfer, S, Bui, B, Schoffski, P, Ouali, M, Marreaud, S, Brouste, V, Duhamel, A, Hohenberger, P, Blay, J-Y
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101912/
https://www.ncbi.nlm.nih.gov/pubmed/21505457
http://dx.doi.org/10.1038/bjc.2011.136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101912/
https://www.ncbi.nlm.nih.gov/pubmed/21505457
http://dx.doi.org/10.1038/bjc.2011.136

Ejemplares similares